Market Place
Sourcing Support
J&J Puts Blockbuster Blood Thinner Xarelto On Trumprx
27 Apr 2026 //
BIOSPACE
Johnson & Johnson to offer four prescription medicines on TrumpRx
27 Apr 2026 //
REUTERS
Johnson & Johnson Offers Four Prescription Medicines On Trumprx
24 Apr 2026 //
REUTERS HEALTHCARE
Bayer falls short in bid to block J&J’s survival claims
20 Apr 2026 //
FIERCE PHARMA
U.S. Judge Rejects Bayer Bid to Block J&J Cancer Claims
19 Apr 2026 //
FIRSTWORD PHARMA
J&J to Participate in Bank of America 2026 Healthcare Conference
15 Apr 2026 //
BUSINESSWIRE
J&J Targets $100B Revenue by 2026 After Strong Q1
14 Apr 2026 //
BIOSPACE
J&J Showcases Clinical Data for TECNIS PureSee IOL at ASCRS 2026
10 Apr 2026 //
BUSINESSWIRE
Nanobiotix Presents Ph2 Data JNJ-1900 Stage 3 Lung Cancer
30 Mar 2026 //
GLOBENEWSWIRE
Pharma R&D Spend Decreases By 3.6% Amid Pipeline Prioritization
25 Mar 2026 //
BIOSPACE
J&J Leads Pharma Revenue; Lilly Surges With Obesity Sales
18 Mar 2026 //
BIOSPACE
J&J Changes New York State Of Mind, Closing JLABS Site
17 Mar 2026 //
FIERCE BIOTECH
Johnson & Johnson Drives Innovation In Pulsed Field Ablation
16 Mar 2026 //
BUSSINESSWIRE
J&J Alleges Trade Secret Theft By Former Staffer Linked To Summit
16 Mar 2026 //
FIERCE PHARMA
Johnson & Johnson Announces FDA Approval Of TECNIS Puresee
12 Mar 2026 //
BUSSINESSWIRE
J&J Chief Joaquin Duato Collects Sizable Pay Raise For 2025
11 Mar 2026 //
FIERCE PHARMA
Johnson & Johnson to Host Investor Conference Call on Q1 Results
02 Mar 2026 //
BUSINESSWIRE
Bayer Sues J&J Over `Deeply Flawed` Erleada Promotional Claims
23 Feb 2026 //
FIERCE PHARMA
Law firm in J&J baby powder cases sues its litigation funders
13 Feb 2026 //
REUTERS
J&J Liable In Pennsylvania Talc Cancer Trial
13 Feb 2026 //
REUTERS
Johnson & Johnson Joins Barclays Global Healthcare Conference
09 Feb 2026 //
BUSINESSWIRE
Head-to-Head Analysis shows 51% reduction in Risk of Death
02 Feb 2026 //
PR NEWSWIRE
Johnson & Johnson at TD Cowen 46th Healthcare Conference
02 Feb 2026 //
BUSINESSWIRE
J&J Targets $100B Sales, Overcomes Stelara Patent Cliff
22 Jan 2026 //
BIOSPACE
Expert Testimony Will Be Allowed In J&J Talc Litigation In N.J.
22 Jan 2026 //
FIERCE PHARMA
Johnson & Johnson Reports Q4 And Full-Year 2025 Results
21 Jan 2026 //
BUSINESSWIRE
Johnson & Johnson Advances Depression Leadership With New Data
13 Jan 2026 //
PR NEWSWIRE
Johnson & Johnson Announces Multibillion Dollar Facility in NC
13 Jan 2026 //
CONTRACTPHARMA
Veristat Names Kim McLean Boericke as CEO
13 Jan 2026 //
CONTRACTPHARMA
J&J Reveals US Drug Pricing Deal And Plans To Build 2 US Plants
09 Jan 2026 //
FIERCE PHARMA
Johnson & Johnson Enhances Medicine Access And Lowers Costs
09 Jan 2026 //
PHARMIWEB
Lilly, J&J Top Clarivate`s 2026 Drugs to Watch
07 Jan 2026 //
FIERCE PHARMA
J&J`s Tremfya Closes Out 2025 As December`s Top TV Ad Spender
06 Jan 2026 //
FIERCE PHARMA
Johnson & Johnson Declares Q1 2026 Dividend
02 Jan 2026 //
BUSINESSWIRE
J&J Halts Mid-stage Trial of Experimental Eczema Drug
27 Dec 2025 //
REUTERS
J&J vows appeal after US jury hits it with record $1.5B talc
27 Dec 2025 //
REUTERS
Europe Greenlights TREMFYA For Pediatric Plaque Psoriasis
19 Dec 2025 //
PHARMIWEB
Johnson & Johnson Hosts Investor Call On Q4 Results
15 Dec 2025 //
BUSINESSWIRE
FDA `Proactively` Awards J&J A National Priority Review Voucher
15 Dec 2025 //
FIERCE PHARMA
Update On Phase 3 Librexia ACS Trial
15 Nov 2025 //
BUSINESSWIRE
J&J Survey Underscores The Power Of Patient Community In IBD
07 Nov 2025 //
FIERCE PHARMA
FDA Approval of Caplyta for Major Depressive Disorder
06 Nov 2025 //
PR NEWSWIRE
Johnson & Johnson Joins Citi`s 2025 Global Healthcare Conference
05 Nov 2025 //
BUSINESSWIRE
Nanobiotix Finds New Way to Source Cash from J&J-Partnered Drug
31 Oct 2025 //
FIERCE BIOTECH
Texas AG Sues Kenvue Over Alleged Tylenol-Autism Link
28 Oct 2025 //
FIERCE PHARMA
Johnson & Johnson Joins 7Th Wolfe Research Healthcare Conference
22 Oct 2025 //
BUSINESSWIRE
J&J Signs On As The New York Jets` Medical Innovation Sponsor
22 Oct 2025 //
FIERCE PHARMA
Johnson & Johnson Boosts 2025 Sales Forecast After Q3 Results
14 Oct 2025 //
BUSINESSWIRE
Johnson & Johnson Declares Q4 2025 Dividend
14 Oct 2025 //
BUSINESSWIRE
J&J Chief Duato `Optimistic` Amid MFN Discussions With Trump
14 Oct 2025 //
FIERCE PHARMA
J&J Eyes Takeover Of Immunology Partner Protagonist: WSJ
11 Oct 2025 //
FIERCE BIOTECH
J&J Recommend Shareholders Reject “mini-Tender” Offer by Tutanota
10 Oct 2025 //
BUSINESSWIRE
Johnson & Johnson Showcases Major Depressive Disorder Portfolio
10 Oct 2025 //
PR NEWSWIRE
Johnson & Johnson Joins UBS Global Healthcare Conference
09 Oct 2025 //
BUSINESSWIRE
J&J Will Appeal $966M Award By LA Jury In Talcum Powder Lawsuit
07 Oct 2025 //
FIERCE PHARMA
Johnson & Johnson Joins Guggenheim Securities Healthcare Conf
06 Oct 2025 //
BUSINESSWIRE
MMS, Gates Ventures, GNPC Deliver Major Proteomics Dataset
02 Oct 2025 //
PHARMIWEB
Former Abiomed Ceo Launches Bid For Massachusetts Governor
01 Oct 2025 //
FIERCE BIOTECH
J&J to Present Neuropsychiatry Innovation at 2025 Psych Congress
15 Sep 2025 //
PR NEWSWIRE
Novartis Falls in Another IRA Price Negotiation Loss for Pharma
12 Sep 2025 //
FIERCE PHARMA
